Literature DB >> 28598825

Retinoic acid-related orphan receptor alpha (RORA) variants and risk of breast cancer.

Mohammad Taheri1,2, Mir Davood Omrani1,2, Rezvan Noroozi1, Soudeh Ghafouri-Fard1, Arezou Sayad1.   

Abstract

BACKGROUND: Breast cancer is the most common type of cancer and the second leading cause of cancer death in females. Despite numerous studies in this field, the etiology and clinical behavior of breast tumors have not been understood yet. Retinoid orphan nuclear receptor alpha (RORA) is a member of the orphan nuclear factor family involved in the regulation of lipid and steroid metabolism, immune response and circadian rhythms. Recent evidences support its role as a tumor suppressor gene.
OBJECTIVES: To find the associations between RORA polymorphisms and breast cancer.
METHODS: In the present study, we evaluated the association between two functional polymorphisms in RORA (rs11639084 and rs4774388) and breast cancer risk in a population of 122 Iranian breast cancer patients as well as 200 healthy subjects by means of tetra primer-amplification refractory mutation system-PCR (4P-ARMS-PCR) method.
RESULTS: The rs4774388 has been shown to be associated with breast cancer risk in recessive inheritance model (OR (95% CI ) = 0.51 (0.26-0.97) and P = 0.041). However, the allele and genotype frequencies of rs11639084 were not different in patients and control (P > 0.05). Haplotype analysis revealed no significant association of any estimated block of rs11639084/rs4774388 in breast cancer patients versus healthy controls.
CONCLUSIONS: The results of this study support a putative role for RORA in breast cancer pathogenesis.

Entities:  

Keywords:  RORA; breast cancer; polymorphism

Mesh:

Substances:

Year:  2017        PMID: 28598825     DOI: 10.3233/BD-160248

Source DB:  PubMed          Journal:  Breast Dis        ISSN: 0888-6008


  4 in total

1.  Chemopreventive efficacy of stampidine in a murine breast cancer model.

Authors:  Kazim Sahin; Cemal Orhan; Ibrahim Hanifi Ozercan; Mehmet Tuzcu; Birsen Elibol; Taha Koray Sahin; Ulkan Kilic; Sanjive Qazi; Fatih Mehmet Uckun
Journal:  Expert Opin Ther Targets       Date:  2020-02-05       Impact factor: 6.902

2.  Rora Regulates Neutrophil Migration and Activation in Zebrafish.

Authors:  Alan Y Hsu; Tianqi Wang; Ramizah Syahirah; Sheng Liu; Kailing Li; Weiwei Zhang; Jiao Wang; Ziming Cao; Simon Tian; Sandro Matosevic; Christopher J Staiger; Jun Wan; Qing Deng
Journal:  Front Immunol       Date:  2022-03-04       Impact factor: 7.561

3.  ROR activation by Nobiletin enhances antitumor efficacy via suppression of IκB/NF-κB signaling in triple-negative breast cancer.

Authors:  Eunju Kim; Yoon-Jin Kim; Zhiwei Ji; Jin Muk Kang; Marvin Wirianto; Keshav Raj Paudel; Joshua A Smith; Kaori Ono; Jin-Ah Kim; Kristin Eckel-Mahan; Xiaobo Zhou; Hyun Kyoung Lee; Ji Young Yoo; Seung-Hee Yoo; Zheng Chen
Journal:  Cell Death Dis       Date:  2022-04-19       Impact factor: 9.685

4.  Identification of Potential Prognostic Biomarkers for Breast Cancer Based on lncRNA-TF-Associated ceRNA Network and Functional Module.

Authors:  Xinrong Li; Junquan Zhu; Jian Qiu
Journal:  Biomed Res Int       Date:  2020-07-28       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.